terbium has been researched along with Prostatic Neoplasms, Castration-Resistant in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Burgard, C; Ezziddin, S; Khreish, F; Maus, S; Rosar, F; Schaefer-Schuler, A | 1 |
1 other study(ies) available for terbium and Prostatic Neoplasms, Castration-Resistant
| Article | Year |
|---|---|
New Horizons in Radioligand Therapy: 161Tb-PSMA-617 in Advanced mCRPC.
Topics: Aged, 80 and over; Heterocyclic Compounds, 1-Ring; Humans; Lutetium; Male; Positron Emission Tomography Computed Tomography; Prostate-Specific Antigen; Prostatic Neoplasms, Castration-Resistant; Radioisotopes; Terbium; Treatment Outcome | 2023 |